Switch to:

Arrowhead Pharmaceuticals Total Stockholders Equity

: $493.1 Mil (As of Jun. 2020)
View and export this data going back to 1997. Start your Free Trial

Arrowhead Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Jun. 2020 was $493.1 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Arrowhead Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2020 was $4.82. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Arrowhead Pharmaceuticals's Debt-to-Equity for the quarter that ended in Jun. 2020 was 0.04.


Arrowhead Pharmaceuticals Total Stockholders Equity Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 110.18 95.58 81.42 95.80 244.59

Arrowhead Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 226.23 244.59 500.08 494.12 493.14

Arrowhead Pharmaceuticals  (NAS:ARWR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Arrowhead Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2020 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Arrowhead Pharmaceuticals's Debt-to-Equity for the quarter that ended in Jun. 2020 is

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals Total Stockholders Equity Related Terms


Arrowhead Pharmaceuticals Total Stockholders Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)